2005Shanghai Journal of Traditional Chinese MedicineRequires access

Clinical Evaluation of “Feiji Decoction” in Treating Non-small Cell Lung Cancer in 61 Cases

Jie You

Open publisher page 1 citations

Abstract

To observe the clinical efficacy of “Feiji Decoction” in the treatment of non small cell lung cancer(NSCLC), 102 subjects were randomized into two groups: observation group in which 61 cases were treated with “Feiji Decoction” and chemotherapy and control group in which 41 cases were treated with simple chemotherapy. The clinical symptoms, survival quality scale and specific lung cancer module were observed. Results: After treatment, the symptoms were alleviated in observation group and tended to worsen in control group. Conclusion: “Feiji Decoction” can relieve NSELC symptoms and its chemotherapeutic symptoms.

About this research paper

What this paper is about

To observe the clinical efficacy of “Feiji Decoction” in the treatment of non small cell lung cancer(NSCLC), 102 subjects were randomized into two groups: observation group in which 61 cases were treated with “Feiji Decoction” and chemotherapy and control group in which 41 cases were treated with simple chemotherapy. The clinical symptoms, survival quality scale and specific lung cancer module were observed. Results: After treatment, the symptoms were alleviated in observation group and tended to worsen in control group. Conclusion: “Feiji Decoction” can relieve NSELC symptoms and its chemotherapeutic symptoms.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To observe the clinical efficacy of “Feiji Decoction” in the treatment of non small cell lung cancer(NSCLC), 102 subjects were randomized into two groups: observation group in which 61 cases were treated with “Feiji Decoction” and chemotherapy and control group in which 41 cases were treated with simple chemotherapy. The clinical symptoms, survival quality scale and specific lung cancer module were observed. Results: After treatment, the symptoms were alleviated in observation group and tended to worsen in control group. Conclusion: “Feiji Decoction” can relieve NSELC symptoms and its chemotherapeutic symptoms.

Key concepts: Medicine, Decoction, Lung cancer, Chemotherapy, Internal medicine, Traditional Chinese medicine, Cancer, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Evaluation of “Feiji Decoction” in Treating Non-small Cell Lung Cancer in 61 Cases — Research Paper | ScholarLens